• Mashup Score: 0
    Submission - 1 year(s) ago

    The study was initiated in Q1 2021 and is ongoing. The ultimate goal is to ensure that evidence for (or against) the surrogacy of biomarkers studied in clinical trials of AL amyloidosis can be evaluated and published by the research community without delay.  Such data are necessary for evaluating surrogacy and accelerating development of effective therapies. A scientific abstract reporting…

    Tweet Tweets with this article
    • Today is the last day for voting! The #Amyloidosis Forum (an ARC partnership) has made it through to the final round of the HeroX DataWorks! Challenge! Finalists are eligible for $500,000 prize purse across 12 awards. Help us win and vote here: https://t.co/4EAtEC6qLn

  • Mashup Score: 0
    Submission - 1 year(s) ago

    The study was initiated in Q1 2021 and is ongoing. The ultimate goal is to ensure that evidence for (or against) the surrogacy of biomarkers studied in clinical trials of AL amyloidosis can be evaluated and published by the research community without delay.  Such data are necessary for evaluating surrogacy and accelerating development of effective therapies. A scientific abstract reporting…

    Tweet Tweets with this article
    • Not sure if you've voted in the #DataWorks competition yet? Tap the link below and check if the "Vote for this submission" button is still there or not. Submit your vote now if it is! https://t.co/RYJymoKWBe https://t.co/GTu0CLqp7t

  • Mashup Score: 2

    Create your profile, find a challenge, and start solving! Join a team or form your own, or go solo. Always free, always open.

    Tweet Tweets with this article
    • Here's how to VOTE TODAY: 1. Go to https://t.co/Lo0sqpU19q 2. Create a free HeroX account 3. Click the "Vote for this submission" button on the HeroX website 4. Click "Yes" 5. Enter your phone number (HeroX's verification system to make sure only one vote per person is cast)

    • VOTE TODAY and help our #AmyloidosisForum submission to the HeroX #DataWorks challenge win the people's choice recognition award! Only the TOP TWO submissions win and we're currently in THIRD place. We need you! Regiester and vote here: https://t.co/Lo0sqpUyYY #amyloidosis https://t.co/nJm58uJ0jW

  • Mashup Score: 3
    Submission - 1 year(s) ago

    The study was initiated in Q1 2021 and is ongoing. The ultimate goal is to ensure that evidence for (or against) the surrogacy of biomarkers studied in clinical trials of AL amyloidosis can be evaluated and published by the research community without delay.  Such data are necessary for evaluating surrogacy and accelerating development of effective therapies. A scientific abstract reporting…

    Tweet Tweets with this article
    • The Amyloidosis Forum (an ARC partnership) has made it through to the final round of the @IamHeroX DataWorks! Challenge sponsored by @FASEBorg and @NIH. Now we need your help! Vote now to help our #FederatedAnalytics platform win the final round: https://t.co/RYJymoKoLG https://t.co/8vP33QL3q5

  • Mashup Score: 12

    Share your story of how you reused or shared data to further your biological and/or biomedical research effort and get recognized!

    Tweet Tweets with this article
    • RT @atulbutte: Big $500k @NIH prize highlighted at #nihacd, for winning data sharing and data reuse! Learn more at https://t.co/XEvffeXcOs…

    • Big $500k @NIH prize highlighted at #nihacd, for winning data sharing and data reuse! Learn more at https://t.co/XEvffeXcOs! https://t.co/V16yxZdcp5